Medicine Supply Chain Management System
Ensuring transparency in critical drug supply from source to patient.
Medicine Tracking Platform
Pharma Distribution Tool
COVID Drug Monitoring
Supply Chain for Health
This platform brings transparency to pharmaceutical distribution, especially during health crises. Designed for FDA and health departments, it monitors medicine flow from manufacturers to end users, using Aadhaar-linked patient validation to avoid duplication and black marketing.
Features
Transparency in Supply Chain
The platform ensures transparency by capturing and maintaining detailed records of the incoming and outgoing medicines. This includes information about stockists, distributors, retailers, pharmacies, and hospitals involved in the distribution process. By recording all transactions, the platform creates a transparent trail that can be monitored and audited by the FDA to identify any fraudulent activities.
Real-time Monitoring and Fraud Detection
The platform enables real-time monitoring of the availability and movement of COVID-19 medicines. This allows the FDA to have an up-to-date picture of the medicine supply chain, facilitating effective decision-making and proactive interventions to address shortages or prevent fraudulent practices. By identifying anomalies or suspicious activities, the platform helps in detecting and mitigating fraud within the supply chain.
Patient Data Recording
Pharmacies and hospitals using the platform are required to input patient details before selling the medicines. This step helps prevent the misuse of prescriptions and ensures that patients do not obtain the same medicine multiple times from different stores using a single or fraudulent prescription. By recording patient information, the platform adds an additional layer of accountability and prevents unauthorized access to critical medications.
Compliance and Reporting
The platform assists in maintaining compliance with regulations and guidelines set by the FDA and other regulatory authorities. It provides a centralized system for generating reports on medicine transactions, patient data, and overall medicine availability. These reports can be used by the FDA for analysis, regulatory oversight, and decision-making purposes.
Transparency in Supply Chain
The platform ensures transparency by capturing and maintaining detailed records of the incoming and outgoing medicines. This includes information about stockists, distributors, retailers, pharmacies, and hospitals involved in the distribution process. By recording all transactions, the platform creates a transparent trail that can be monitored and audited by the FDA to identify any fraudulent activities.
Real-time Monitoring and Fraud Detection
The platform enables real-time monitoring of the availability and movement of COVID-19 medicines. This allows the FDA to have an up-to-date picture of the medicine supply chain, facilitating effective decision-making and proactive interventions to address shortages or prevent fraudulent practices. By identifying anomalies or suspicious activities, the platform helps in detecting and mitigating fraud within the supply chain.
Patient Data Recording
Pharmacies and hospitals using the platform are required to input patient details before selling the medicines. This step helps prevent the misuse of prescriptions and ensures that patients do not obtain the same medicine multiple times from different stores using a single or fraudulent prescription. By recording patient information, the platform adds an additional layer of accountability and prevents unauthorized access to critical medications.
Compliance and Reporting
The platform assists in maintaining compliance with regulations and guidelines set by the FDA and other regulatory authorities. It provides a centralized system for generating reports on medicine transactions, patient data, and overall medicine availability. These reports can be used by the FDA for analysis, regulatory oversight, and decision-making purposes.
Transparency in Supply Chain
The platform ensures transparency by capturing and maintaining detailed records of the incoming and outgoing medicines. This includes information about stockists, distributors, retailers, pharmacies, and hospitals involved in the distribution process. By recording all transactions, the platform creates a transparent trail that can be monitored and audited by the FDA to identify any fraudulent activities.
Real-time Monitoring and Fraud Detection
The platform enables real-time monitoring of the availability and movement of COVID-19 medicines. This allows the FDA to have an up-to-date picture of the medicine supply chain, facilitating effective decision-making and proactive interventions to address shortages or prevent fraudulent practices. By identifying anomalies or suspicious activities, the platform helps in detecting and mitigating fraud within the supply chain.
Patient Data Recording
Pharmacies and hospitals using the platform are required to input patient details before selling the medicines. This step helps prevent the misuse of prescriptions and ensures that patients do not obtain the same medicine multiple times from different stores using a single or fraudulent prescription. By recording patient information, the platform adds an additional layer of accountability and prevents unauthorized access to critical medications.
Compliance and Reporting
The platform assists in maintaining compliance with regulations and guidelines set by the FDA and other regulatory authorities. It provides a centralized system for generating reports on medicine transactions, patient data, and overall medicine availability. These reports can be used by the FDA for analysis, regulatory oversight, and decision-making purposes.